 | Up a level |
Ferreri, A J M; Illerhaus, G; Doorduijn, J K; Auer, D P; Bromberg, J E C; Calimeri, T; Cwynarski, K; Fox, C P; Hoang-Xuan, K; Malaise, D; Ponzoni, M; Schorb, E; Soussain, C; Specht, L; Zucca, E; Buske, C; Jerkeman, M; Dreyling, M (2024). Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. (In Press). Annals of oncology Elsevier 10.1016/j.annonc.2023.11.010
Leich, E; Hoster, E; Wartenberg, Martin; Unterhalt, M; Siebert, R; Koch, K; Klapper, W; Engelhard, M; Puppe, B; Horn, H; Staiger, A M; Stuhlmann-Laeisz, C; Bernd, H W; Feller, A C; Hummel, M; Lenze, D; Stein, H; Hartmann, S; Hansmann, M L; Möller, P; ... (2016). Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. Leukemia, 30(4), pp. 854-860. Nature Publishing Group 10.1038/leu.2015.330
Fey, M F; Dreyling, M (2010). Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 21 Suppl 5, v158-v161. Oxford: Oxford University Press 10.1093/annonc/mdq179
Fey, M; Dreyling, M (2009). Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 20 Suppl 4, pp. 100-101. Oxford: Oxford University Press 10.1093/annonc/mdp141
Fey, M; Dreyling, M (2008). Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii58-9. Oxford: Oxford University Press 10.1093/annonc/mdn089
